Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 3,076,924
- Share change
- +1,494,613
- Total reported value
- $15,505,000
- Price per share
- $5.02
- Number of holders
- 20
- Value change
- +$7,596,691
- Number of buys
- 4
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
3.8%
|
1,093,219
|
$3,892,000 | — | 30 Jun 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
100,000
|
$356,000 | — | 30 Jun 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.31%
|
88,978
|
$317,000 | — | 30 Jun 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.24%
|
69,217
|
$246,000 | — | 30 Jun 2016 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.24%
|
68,495
|
$244,000 | — | 30 Jun 2016 | |
| Artal Group S.A. |
13F
|
Company |
0.22%
|
64,102
|
$228,000 | — | 30 Jun 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
29,558
|
$105,000 | — | 30 Jun 2016 | |
| Destination Wealth Management |
13F
|
Company |
0.07%
|
20,696
|
$74,000 | — | 30 Jun 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
14,961
|
$53,000 | — | 30 Jun 2016 | |
| Paloma Partners Management Co |
13F
|
Company |
0.04%
|
11,763
|
$42,000 | — | 30 Jun 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.02%
|
6,651
|
$24,000 | — | 30 Jun 2016 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
4,014
|
$14,000 | — | 30 Jun 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
2,817
|
$9,000 | — | 30 Jun 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,119
|
$8,000 | — | 30 Jun 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
1,899
|
$7,000 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
970
|
$3,000 | — | 30 Jun 2016 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$3,000 | — | 30 Jun 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
730
|
$3,000 | — | 30 Jun 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
647
|
$2,000 | — | 30 Jun 2016 | |
| Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) |
13F
|
Company |
0%
|
550
|
$2,000 | — | 30 Jun 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
478
|
$2,000 | — | 30 Jun 2016 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
465
|
$2,000 | — | 30 Jun 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
462
|
$2,000 | — | 30 Jun 2016 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
305
|
$1,000 | — | 30 Jun 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
265
|
$1,000 | — | 30 Jun 2016 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
210
|
$1,000 | — | 30 Jun 2016 | |
| Sonora Investment Management, LLC |
13F
|
Company |
0%
|
50
|
$178 | — | 30 Jun 2016 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q3 2016
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.